TheradaptiveTheradaptive
Theradaptive

Theradaptive

Biotech company developing targeted regenerative therapeutics using a proprietary protein engineering platform for tissue repair.

2017Active31

About

Theradaptive develops regenerative therapeutics by engineering material-binding variants of recombinant proteins that coat implants and devices. This platform enables precise, localized, and long-lasting therapeutic delivery to treat orthopedic injuries, spinal fusion, and other tissue repair needs.

Technology stack

detected 2026-06-18
Est. monthly stack spend~$380/mo
Emailunknown
Hosting
self_managed
Stack
jQueryBootstrapWordPress
Analytics
Google Analytics 4
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Theradaptive do?

Theradaptive develops regenerative therapeutics by engineering material-binding variants of recombinant proteins that coat implants and devices. This platform enables precise, localized, and long-lasting therapeutic delivery to treat orthopedic injuries, spinal fusion, and other tissue repair needs.

How much funding has Theradaptive raised?

Theradaptive has raised a total of $32M in funding. The most recent round on record is Series A.

Where is Theradaptive headquartered?

Theradaptive is headquartered in Frederick, United States.

When was Theradaptive founded?

Theradaptive was founded in 2017.

What industry does Theradaptive operate in?

Theradaptive operates in Biotech, Regenerative Medicine, Protein Engineering, Medical Devices.

How many employees does Theradaptive have?

Theradaptive has approximately 31 people on record.